A Phase I, Multi-Center, Open-Label, Single-Dose, 2 Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese and Chinese Subjects

Trial Profile

A Phase I, Multi-Center, Open-Label, Single-Dose, 2 Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese and Chinese Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Gepotidacin (Primary)
  • Indications Gonorrhoea; Respiratory tract infections; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Aug 2017 Planned End Date changed from 17 Aug 2017 to 6 Nov 2017.
    • 08 Aug 2017 Planned primary completion date changed from 1 May 2017 to 6 Nov 2017.
    • 31 Mar 2017 Planned End Date changed from 1 May 2017 to 17 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top